Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Anxiety Disorders 2Weight Loss 1Recurrence 1Lung Neoplasms 1Glioma 1Fatigue 1Depression 1Colorectal Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Brain Neoplasms 1Advanced Cancer 1Adenocarcinoma of Lung 1

Interventions

Therapeutics 31Psychiatric Rehabilitation 27Surveys and Questionnaires 15Cognitive Behavioral Therapy 12Early Intervention, Educational 10Psilocybin 9Ketamine 9Methods 8Saline Solution 7Yoga 6Mindfulness-Based Cognitive Therapy 6Interviews as Topic 6Esketamine 6Counseling 6Psychosocial Intervention 5Mindfulness 5Methylphenidate 5Escitalopram 5Educational Status 5Behavior Therapy 5Acupuncture Therapy 5Palliative Care 4Exercise Therapy 4Exercise 4Control Groups 4Caregivers 4Standard of Care 3Psychotherapy 3Niacin 3Mindfulness-Based Stress Reduction 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depression × Fluoxetine × Clear all
NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
21 enrolled
Thoracic

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡